It is well known that PR/SET family members participate in transcriptional regulation via chromatin remodeling. PRDM10 might play an essential role in gene expression, but no such evidence has been observed so far. To assess PRDM10 expression at various stages of mouse development, we performed immunohistochemistry using available PRDM10 antibody. Embryos were obtained from three distinct developmental stages. At E8.5, PRDM10 expression was concentrated in the mesodermal and neural crest populations. As embryogenesis proceeded further to E13.5, PRMD10 expression was mainly in mesoderm-derived tissues such as somites and neural crest-derived populations such as the facial skeleton. This expression pattern was consistently maintained to the fetal growth period E16.5 and adult mouse, suggesting that PRDM10 may function in tissue differentiation. Our study revealed that PRDM10 might be a transcriptional regulator for normal tissue differentiation during mouse embryonic development. [BMB reports 2010; 43(1): 29-33]
INTRODUCTION
PRDM contains a PR (PRDI-BF1 and RIZ homology) domain and is a subgroup of PR/SET transcription factor family, because its PR domain shows similarity to the catalytic motif of the SET domain of histone methyltransferase (HMTase) (1, 2) . There are approximately 20 PR and 30 SET domain-containing genes in the human genome, a growing number of which have been found to possess intrinsic HMT activity towards specific lysine residues along the N-terminal tails of histones (2) (3) (4) (5) . These histone-modifying proteins participate in the regulation of genome expression and chromatin remodeling.
Most of the PRDM subfamily has been implicated in cell proliferation and gene repression in cancer and normal mammalian development (6) (7) (8) . Human PRDM2 (also known as RIZ1) is a strong tumor suppressor that induces G2/M cell cycle arrest and/or apoptosis in various tumor cells (6, 9, 10) . Its PR domain can methylate histone H3 lysine 9 (H3K9) and is necessary in the repression of estrogen signaling genes (3, 11) . Deletion of mouse PRDM2 was closely associated with B cell lymphoma in a knockout mouse experiment (10) . Mouse PRDM1 (also known as Blimp1) has been identified as a key factor for PGC (primordial germ cell) specification, which is the major source for oocytes and spermatozoa (12) . Interestingly, PGC specification requires the concerted orchestration of two PR domain-containing transcriptional regulators, PRDM1 and PRDM14 (13) . PRDM14 is a key protein in the launching of the germ cell lineage in mice, suggesting that this event is accomplished by the sequential expression of multiple genes (13) . PRDM14 also maintains the self-renewal of human ES cells by suppressing gene expression in embryoid bodies (14) . The expression of multiple PRDM family genes (PRDM6, 8, 12, 13 and 16) in the developing mouse central nerve system occurs in a spatially and temporally restricted manner, thereby generating a great deal of interest. PRDM8 and 12 are found in the neuronal progenitor zones of developing spinal cord, where as PRDM12 and 16 occur in the ventricular zone of developing telencephalon in a lateral to medial graded manner; PRDM8 also is present in postmitotic neurons. This suggests that dynamic changes in PRDM family genes occur in the developing embryo (15) .
In this study, we examined the expression of PRDM10 during mouse embryogenesis. Immunohistochemical analysis was performed on sections obtained from distinct developmental stages of the embryo during embryo to fetus or tissue differentiation.
RESULTS

Expression of PRMD10 at the embryo to fetus differentiation (E8.5)
Immunohistochemistry (IHC) with antibodies specific to PRDM10 was used to examine. PRDM10 expression during various stages of mouse embryogenesis 8.5 to 16.5 days post-coitus. Hematoxylin counterstaining was used as a control. During early stages (E8.5), PRDM10 was strongly expressed in the middle embryo region, suggesting a cell population in the paraxial mesodermal or migrating neural crest regions as shown in Fig. 1 . All mesenchymal cell populations can differentiate after neural tube closure according to pro-http://bmbreports.org gramming (16, 17) . Therefore, PRDM10 is likely expressed in robust mesenchymal cells derived from the mesoderm and neural crest during early mouse development.
PRMD10 expression in somital and craniofacial tissues during organogenesis
To assess PRDM10 expression during late mouse development, sagittal sections from E13.5 were analyzed. Compared to the IgG negative control, PRDM10 was mainly expressed in the craniofacial, somital and notochord regions (Fig. 2) . PRDM10 expression was also apparent in the ventricles at this stage, but not in the intestines or liver. Although experiments were not quantitative, the relative levels of PRDM10 expression are apparent. A more detailed examination was performed using sagittal sections of the embryo obtained from E16.5. As shown in Fig. 3 , IHC demonstrated that PRDM10 is ubiquitously expressed patterns in various tissues. Specifically, PRDM10 was mainly visible in the developing reticular dermis layer of differentiated head tissues (Fig. 3A) , mandible regions (Fig. 3B) , and the adrenal medulla (Fig. 3C) , but was concentrated in the skeletal cartilage (Fig.  3D ). Since these PRDM10-expressing tissues were mainly derived from mesodermal or neural crest cell populations, the results suggest that PRDM10 is consistently expressed for mesodermal differentiation during mouse development.
PRMD10 expression in adult mouse tissues
Adult mice were sacrificed in order to examine PRDM10 expression in various tissues by IHC and RT-PCR analysis. IHC detected PRDM10 expression in cartilage and kidney, in agreement with PRDM10 expression during embryonic development (Fig. 4A) . However, RT-PCR analysis found that the patterns of PRDM10 expression in certain tissues, such as liver, spleen and rectum, were slightly different compared to embryonic stages, suggesting that PRDM10 is distinctly expressed in adult mice (Fig. 4B) . This discrepancy could be explained by the fact that the embryonic tissues were too small. Therefore, these results suggest that PRDM10 plays a role in tissue differentiation during mouse embryogenesis and adult development.
DISCUSSION
Although PRDM10 shares characteristics with the PR/SET fam-http://bmbreports.org BMB reports RT-PCR analysis of PRDM10 expression in various mouse tissues. cDNA was prepared from various tissues and used as a DNA template for PCR amplification using PRDM10 specific primers. A single band of PRDM10 was detected at 401 bp. GAPDH was used as a loading control to confirm correct cDNA synthesis.
ily with the PR/SET domain and clusters of krüppel-like zinc fingers DNA binding motifs, the functions of PRDM10 are only beginning to be determined (18) . It is known that most of the PR/SET gene family modulates gene expression, specifically the spatial and temporal regulation of tissue differentiation during mouse embryonic development (5, 15, 19, 20) . Functionally, PR/SET gene family members directly or indirectly interact with histone methylation proteins that possess HMTase activity as well as components of the transcription machinery (1, 8, 11) . Our present study suggests that PRDM10 expression stimulates the sophisticated morphogenesis of tissue differentiation, including somites and craniofacial tissue formation. Therefore, we postulate http://bmbreports.org that PRDM10 has an essential role in regulating gene expression by binding target gene promoters and regulating tissue differentiation genes. PRDM10 could be recruited to its target promoters, depending on the activity derived from its conserved PR/SET domain. Even though the intrinsic activity of PRDM10 remains unknown, we have consistently obtained data showing that PRDM10 is a tri-H3K9 HMTase-related protein (unpublished data). In general, silenced genes are associated with tri-methylated H3K9, which represses transcription (11) . This suggests that PRDM10 expression during mouse embryonic development may function as a gene repressor for normal somite and craniofacial formation.
Previous reports have suggested that PRDM10 may be involved in the pathogenesis of gangliosidosis (GM2), a neuronal storage disease (18) . Based on its high expression in the mesodermal region, PRDM10 might be associated with the pathogenesis of the other mesoderm-derived diseases as well. Therefore, further studies are needed to explore the relationship between PRDM10 expression and diseases associated with cartilage defects such as chondroma or inflammatory arthritis. Although there is no expression data for craniofacial syndromes, these diseases have genetic backgrounds containing mutated candidate target genes (21) . PRDM10 might also be an important target protein for the growth and development of the craniofacial complex based on its expression in craniofacial tissues.
In summary, our study suggests that PRDM10 was expressed in somites and craniofacial tissues during mouse embryonic development. PRDM10 may be a target gene for tissue differentiation and bone formation defects.
MATERIALS AND METHODS
Antibody and reagents
Polyclonal PRDM10 antibody was kindly provided from Abgents Inc. (CA, USA). Secondary antibody was purchased from Santa Cruz Inc. (CA, USA). Reagents for IHC analysis were obtained from Vector Laboratories, Inc. (MI, USA). 3,3'-diaminobenzidine (DAB) was used as a chromogenic substrate and was counterstained with hematoxylin.
Animals and mating
Eight week-old ICR mice were obtained from Orient Bio Inc. (Korea) and either used for mating or sacrificed for further analysis. Mating was performed according to a 3 : 1 female to male ratio and was verified by vaginal plug formation. The embryonic stage was designated embryonic day 0.5 (E0.5) on the day of vaginal plug formation. Embryos or fetuses were prepared on E8.5, E13.5 and E16.5. Animals were handled according to the Guide for the Care and Use of Laboratory Animals at Kangwon National University, Chuncheon, S. Korea.
Immunohistochemistry (IHC)
Following Forane anaesthesia, embryos were removed from the maternal uterus and fixed in neutral formalin for 2 days, after which they were cut in half and fixed in neutral formalin for an additional 3 days. The fixed samples were processed in gradient alcohols, xylene and embedded in paraffin prior to being sectioned at 4 μm for IHC analysis. Paraffin was removed from sections using a citrus clearing solvent for 20 min. To block endogenous peroxidase activity, sections were incubated in a 3% hydrogen peroxidase-methanol mixture for 15 min. Primary PRDM10 antibody was diluted 1 : 100, incubated for 2 hours, and treated with secondary antibody. Chromogenic DAB was used as a substrate and was couterstained with hematoxylin. Finally, the slides were hydrated through alcohol, cleared with citrus clearing solvent and mounted with Permount mounting medium (Fisher Scientific Inc., NJ, USA).
RT-PCR
Adult ICR mouse tissues were collected and examined by RT-PCR. Total cellular RNA was extracted from homogenized tissues using trizol reagent (Promega Co., WI, USA). cDNA was synthesized using reverse-transcriptase according to the manufacturer's instructions and was used as template for PCR amplification along with PRDM10-specific primers. 
